Hereditary Brain Cancer and Glioblastoma Multiforme
Dear OncoLink,   My mother has recently been diagnosed as having a glioblastoma. I wonder if you could suggest a source for information regarding genetic causes. I had an uncle die from the same tumor eight months ago. Can you make any suggestions?   With Kind Regards, DS Nancy J. O'Connor, RN, MSN, CRNP,

Treatment for Optic Nerve Glioma
Dear OncoLink "Ask the Experts," My son has optic nerve glioma of his right eye. His doctor suggested that he should get proton beam therapy. Unfortunately it is not available in my country. Please let you know how this problem can be treated.   Thank you in advance. F Eric Shinohara, MD, MSCI Radiation Oncology Section

Treatment for Glioblastoma Multiforme
My friend, aged 38, is suffering from glioblastoma multiforme for the past 2 years. He has undergone surgery, but the cancer in the brain could not be totally removed. Recently, he was diagnosed as having fluid accumulation in the brain and had another operation to remove the fluid. X-ray could not find the tumor anymore. The doctor has

Essay From Dr. Carl Friedlander, A Brain Cancer Survivor
This document is an attempt on my part to provide people with my view of the history of my past almost four and a half years. During this period I have been dealing with brain cancer and a collection of related drug induced side...

Hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme

Podcast from Opportunities in Proton Therapy: Chordoma/Chondrosarcoma
Subscribe to OncoLink Podcasts You may also use Quicktime to view the individual presentation: Chordoma/Chondrosarcoma Norbert J. Liebsch, M.D., Ph.D., Assistant Professor of Radiation Oncology, Massachusetts General Hospital Cancer Center,...

Podcast from Opportunities in Proton Therapy: Craniopharyngioma
Subscribe to OncoLink Podcasts You may also use Quicktime to view the individual presentation: Craniopharyngioma Claire Alapetite, M.D, Ph.D., Institut Curie, Radiation Oncology Department, Paris, and Institut Curie Centre de...

RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM)
Presenter: Mark R. Gilbert, MD Presenter's Affiliation: University of Texas MD Anderson Cancer Center Department of Neuro-Oncology, Houston, Tx Background Glioblastoma Multiforme (GBM) is the most common primary malignant brain tumor in adults, accounting for 40% of primary CNS malignancies. The standard of care for patients diagnosed with

Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM).  Conclusive results of a radomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials Group.
Presenter: R. StuppPresenter's Affiliation: University Hospital (CHUV), Lausanne, SwitzerlandType of Session: PlenaryBackground Glioblastoma multiforme is the most malignant and most common primary brain tumor, with a dismal median overall survival of less than one year. Radiation treatment has long been the standard of care in treating GBM.

Proton Beam Radiation Therapy Treatment of Pediatric Patients: A 2011 Survey of the U.S. Proton Centers
Presenting Author: A. Chang, MD Presenting Author Affiliation: Hampton University Proton Therapy Institute, Hampton Background Proton beam radiation has unique physical characteristics that allow optimal dose distribution to tumors while minimizing normal tissue irradiation. Pediatric patients are at particular risk for the late side